Warfarin and other anticoagulants: monitoring of patients during the COVID-19 pandemic

The MHRA has issued advice to healthcare professionals and patients regarding the safe use of warfarin and other anticoagulants, following concerns over an apparent increase in the number of patients taking warfarin found to have an elevated INR during the COVID-19 pandemic.

Medicines and Healthcare products Regulatory Agency